Volue ASA carries a market capitalization of 6.00B, placing it among publicly traded companies globally. Its enterprise value stands at 4.49B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 6.00B |
| Enterprise Value | 4.49B |
Volue ASA currently has 143.55M shares outstanding.
| Shares Outstanding | 143.55M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Volue ASA trades at a trailing price-to-earnings ratio of 194.03. The price-to-sales ratio is 2.78, and the price-to-book ratio stands at 5.01.
| PE Ratio | 194.03 |
| PS Ratio | 2.78 |
| PB Ratio | 5.01 |
| P/TBV Ratio | -18.73 |
| P/FCF Ratio | 11.13 |
| P/OCF Ratio | 13.30 |
On an enterprise value basis, Volue ASA trades at an EV/EBITDA multiple of 58.45 and an EV/FCF ratio of 10.84. The EV/Sales ratio of 2.88 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 58.45 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.88 |
| EV / EBITDA | 58.45 |
| EV / EBIT | 58.45 |
| EV / FCF | 10.84 |
Volue ASA maintains a current ratio of 0.89, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 37.25, indicating elevated leverage, while an interest coverage ratio of 1.88 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.89 |
| Quick Ratio | 0.26 |
| Debt / Equity | 37.25 |
| Debt / EBITDA | 4.42 |
| Interest Coverage | 1.88 |
Volue ASA posts a return on equity of 0.83 and a return on invested capital of 3.43.
| Return on Equity (ROE) | 0.83 |
| Return on Assets (ROA) | 1.11 |
| Return on Invested Capital (ROIC) | 3.43 |
| Return on Capital Employed (ROCE) | 1.53 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 27.72 |
Over the trailing twelve months, Volue ASA has paid 15.80M in income taxes, reflecting an effective tax rate of 41.39.
| Income Tax | 15.80M |
| Effective Tax Rate | 41.39 |
Volue ASA's stock has gained approximately 132.44147% over the past 52 weeks. The 50-day moving average sits at 41.66, while the 200-day moving average is 33.29.
| Beta (5Y) | N/A |
| 52-Week Price Change | 132.44147% |
| 50-Day Moving Average | 41.66 |
| 200-Day Moving Average | 33.29 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Volue ASA generated 1.56B in revenue and converted that into 22.37M in net income, yielding earnings per share of 0.15. EBITDA reached 76.78M, while operating income came in at 76.78M.
| Revenue | 1.56B |
| Gross Profit | 681.14M |
| Operating Income | 76.78M |
| Pretax Income | 38.17M |
| Net Income | 22.37M |
| EBITDA | 76.78M |
| EBIT | 76.78M |
| Earnings Per Share (EPS) | 0.15 |
Volue ASA holds 192.57M in cash and equivalents against 339.30M in total debt, resulting in a net debt position of 12.46M. Total book value stands at 865.70M, with working capital of -82.51M providing operational flexibility.
| Cash & Cash Equivalents | 192.57M |
| Total Debt | 339.30M |
| Net Debt | 12.46M |
| Equity (Book Value) | 865.70M |
| Book Value Per Share | 5.97 |
| Working Capital | -82.51M |
Volue ASA produced 326.27M in operating cash flow over the past twelve months. After subtracting -63.83M in capital expenditures, free cash flow totaled 262.44M - equivalent to 1.81 per share.
| Operating Cash Flow | 326.27M |
| Capital Expenditures | -63.83M |
| Free Cash Flow | 262.44M |
| FCF Per Share | 1.81 |
Volue ASA operates with a gross margin of 43.68, reflecting its pricing power and cost economics. The operating margin of 4.92 and net profit margin of 1.43 provide insight into operational efficiency.
| Gross Margin | 43.68 |
| Operating Margin | 4.92 |
| Pretax Margin | 2.45 |
| Profit Margin | 1.43 |
| EBITDA Margin | 4.92 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 4.03 |
| FCF Yield | 8.99 |
Volue ASA posts an Altman Z-Score of -1.53, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.53 |